dutasteride sold brand name avodart among others medication primarily used treat symptoms benign prostatic hyperplasia bph enlarged prostate associated cancer months may required benefits also used scalp hair loss men part hormone therapy transgender usually taken commonly reported side effects dutasteride although rare include sexual dysfunction largest available study men bph experienced erectile dysfunction compared treated placebo experienced decreased sex drive vs placebo enlarged breasts vs exposure pregnancy specifically contraindicated antiandrogens dutasteride shown interfere sexual development male dutasteride patented glaxosmithkline approved medical use united states elsewhere available generic commonly prescribed medication us million dutasteride used treating bph colloquially known enlarged approved food drug administration fda us cochrane review found reduction risk developing prostate cancer inhibitor dutasteride approved treatment male androgenetic alopecia south korea japan dosage mg per several studies found induce hair regrowth men rapidly greater extent even highest approved dosage superior effectiveness dutasteride relative finasteride indication inhibition consequent reduction dihydrotestosterone dht production within hair follicles complete dutasteride dutasteride also used offlabel treatment female pattern hair inhibitors finasteride type inhibitor used offlabel treat excessive hair growth women since dutasteride inhibitor type could theoretically effective therapy hirsutism however dutasteride recommended indication due lack supportive clinical evidence substantial risk birth defects female patients inadvertently become dutasteride sometimes used component hormone therapy transgender women combination estrogen andor another antiandrogen may useful treating scalp hair loss issues tolerating dutasteride provided form soft oilfilled gelatin capsules containing mg dutasteride women may become pregnant handle drug dutasteride cause birth defects male fetuses specifically ambiguous genitalia due antiandrogenic effects similar seen reason women currently pregnant never take people taking dutasteride donate blood prevent birth defects pregnant woman receives blood also donate blood least months cessation treatment due drugs long elimination children people known significant hypersensitivity eg serious skin reactions angioedema dutasteride take dutasteride overall found well tolerated studies men women producing minimal side adverse effects include headache gastrointestinal isolated reports menstrual changes acne dizziness also small risk sexual side effects documented men taking drug first months fda added blackbox warning dutasteride describing increased risk highgrade prostate cancer take direct mechanistic link inhibitors prostate cancer due direct link dutasteride inhibitors cancer per se rather take inhibitors may decrease prostatespecific antigen psa levels therefore increases psa indicator possible cancer may masked take thought delay cancer diagnosis patients taking inhibitors present highergrade tumor time diagnosis american urological association advises increased risk patients taking drugs leads higher prostate cancerspecific allcause aua also advises affect alleviated frequent screening lower psa cutoffs diagnostic biopsies men taking dutasteride dutasteride known reduce growth prevalence benign prostate metaanalysis found higher risk breast cancer sexual mood side effects erectile loss reduced semen volume occur many patients taking inhibitors including affected men semen volume decreased average smaller subgroup patients also experiencing decrease sperm motility sperm shape function unaffected impact male fertility negative effects reverse months discontinuation study men benign prostatic hyperplasia bph condition prostate grows unnassociated cancer erectile dysfunction compared treated placebo experienced decreased sex drive vs placebo enlarged breasts vs effects noted resolve time many fewer men reporting adverse effects end rate discontinuation drug due adverse effects less subset men affected sexual mood side effects report persistent loss erectile dysfunction several years discontinuing remains highly contested topic academic literature due disagreements whether nocebo effect may play whether selfreport questionnaires reliable whether enough objective evidence exists conclude effects persistent discontinuation postfinasteride syndrome foundation pfsf created medical advisory board study topic finasteride similar lawsuits alleging harm drug concerns pfsf patient advocates led fda add blackbox warning finasteride possible risks suicide june experts questioned basis blackbox warning given relies anecdotal patientreported outcomes rather prospective specific antidote overdose dutasteride known since drug extremely safe well tolerated research studies show even times normal dose dutasteride treatment dutasteride overdose based symptoms supportive long elimination halflife dutasteride taken consideration event overdose dutasteride used clinical studies doses mgday week times therapeutic dosage mgday months times therapeutic dosage significant safety concerns additional side dutasteride studied combination bicalutamide treatment prostate ongoing clinical trials investigating whether dutasteride may effective treatment premenstrual dysphoric disorder pmdd dutasteride may inhibit conversion progesterone allopregnanolone neurosteroid metabolite may responsible debilitating symptoms dutasteride belongs class drugs called inhibitors block action enzymes convert testosterone inhibits three forms decrease dht levels blood specifically competitive mechanismbased irreversible inhibitor three isoforms types ii iii halfmaximal inhibitory concentration values nm type nm type contrast finasteride similarly irreversible inhibitor inhibits type ii iii result difference dutasteride able achieve reduction circulating dht levels whereas finasteride able achieve reduction spite differential reduction circulating dht levels two drugs decrease levels dht similar extent approximately prostate type ii isoform since degrade testosterone dht inhibition enzymes could theoretically cause increase testosterone review found initiation inhibitors result consistent increase testosterone among studies analyzed statistically significant change testosterone levels inhibitors overall though men lower baseline testosterone levels show addition inhibition dht production inhibitors dutasteride also neurosteroidogenesis inhibitors preventing biosynthesis various neurosteroids including allopregnanolone progesterone thdoctooltip tetrahydrodeoxycorticosterone deoxycorticosterone neurosteroids potent positive allosteric modulators gabaa receptor shown antidepressant anxiolytic prosexual effects animal reason decreased neurosteroid production one hypothesized mechanism sexual dysfunction depression associated inhibitors oral bioavailability dutasteride consumption food adversely affect peak plasma levels occur hours dutasteride present semen levels ngml significant effects dht levels sexual drug extensively metabolized liver three major metabolites former two formed latter three metabolites active similar inhibitor potency dutasteride two less dutasteride extremely long terminal elimination halflife elimination halflife increased elderly hours men aged years hours men aged dosage adjustment necessary elderly patients renal long elimination halflife dutasteride requires months reach steadystate also remains body long time discontinuation detected contrast dutasteride finasteride short terminal halflife dutasteride eliminated mainly feces smaller portion eliminated unchanged dutasteride also known synthetic androstane steroid analogue finasteride tertbutyl amide moiety replaced dutasteride patented first described scientific literature approved fda treatment bph november introduced united states market following year brand name dutasteride subsequently introduced many countries including throughout europe south patent protection dutasteride expired november drug since become available united states variety lowcost generic approved treatment scalp hair loss south korea japan approved indication united though often used dutasteride generic name drug avodart inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved name jantooltip japanese accepted dutasteride sold primarily brand name avodart also combination tamsulosin brand names combodart dutasteride also available india combination alfuzosin brand names alfusind dutasteride available widely throughout world including united states canada united kingdom ireland many european countries australia south africa well latin america asia available generic medication many countries including united httpsenwikipediaorgwikidutasteride